JP2002513813A5 - - Google Patents

Download PDF

Info

Publication number
JP2002513813A5
JP2002513813A5 JP2000547238A JP2000547238A JP2002513813A5 JP 2002513813 A5 JP2002513813 A5 JP 2002513813A5 JP 2000547238 A JP2000547238 A JP 2000547238A JP 2000547238 A JP2000547238 A JP 2000547238A JP 2002513813 A5 JP2002513813 A5 JP 2002513813A5
Authority
JP
Japan
Prior art keywords
seq
protein
type
papillomavirus
helicase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000547238A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002513813A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA1999/000389 external-priority patent/WO1999057283A1/en
Publication of JP2002513813A publication Critical patent/JP2002513813A/ja
Publication of JP2002513813A5 publication Critical patent/JP2002513813A5/ja
Pending legal-status Critical Current

Links

JP2000547238A 1998-05-01 1999-04-28 ヘリカーゼ活性を有するヒトパピローマウイルスe1の製剤及びその調製方法 Pending JP2002513813A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8394298P 1998-05-01 1998-05-01
US60/083,942 1998-05-01
PCT/CA1999/000389 WO1999057283A1 (en) 1998-05-01 1999-04-28 Preparation of human papillomavirus e1 having helicase activity and method therefor

Publications (2)

Publication Number Publication Date
JP2002513813A JP2002513813A (ja) 2002-05-14
JP2002513813A5 true JP2002513813A5 (https=) 2006-06-22

Family

ID=22181652

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000547238A Pending JP2002513813A (ja) 1998-05-01 1999-04-28 ヘリカーゼ活性を有するヒトパピローマウイルスe1の製剤及びその調製方法

Country Status (9)

Country Link
US (1) US6306580B1 (https=)
EP (1) EP1073750A1 (https=)
JP (1) JP2002513813A (https=)
AU (1) AU767903B2 (https=)
CA (1) CA2326402A1 (https=)
HU (1) HUP0101396A3 (https=)
IL (1) IL139270A0 (https=)
NZ (1) NZ508519A (https=)
WO (1) WO1999057283A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL140524A0 (en) * 1998-07-21 2002-02-10 Boehringer Ingelheim Ca Ltd Regions of papilloma virus e1 helicase involved in e1 oligomerization
WO2000079277A1 (en) 1999-06-17 2000-12-28 Boehringer Ingelheim (Canada) Ltd. NEW ATPase ASSAY
GB0017990D0 (en) * 2000-07-21 2000-09-13 Glaxo Group Ltd Papilloma virus sequences
US7167801B2 (en) 2001-07-12 2007-01-23 Boehringer Ingelheim (Canada) Ltd. Method of identifying potential inhibitors of human papillomavirus protein E2 using x-ray atomic coordinates
AU2003215244A1 (en) * 2002-02-14 2003-09-04 Curagen Corporation Complexes and methods of using same
USD1067594S1 (en) * 2023-07-13 2025-03-25 Wolverine Outdoors, Inc. Footwear sole
USD1067593S1 (en) * 2023-07-13 2025-03-25 Wolverine Outdoors, Inc. Footwear sole
USD1070308S1 (en) * 2023-07-13 2025-04-15 Wolverine Outdoors, Inc. Footwear sole

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5464936A (en) * 1990-12-21 1995-11-07 Cetus Oncology Corporation Compositions for identification of papillomavirus replication inhibitors

Similar Documents

Publication Publication Date Title
Xu et al. Synthesis of a novel hepatitis C virus protein by ribosomal frameshift
Vallbracht et al. Structure-function dissection of pseudorabies virus glycoprotein B fusion loops
Antinone et al. Retrograde axon transport of herpes simplex virus and pseudorabies virus: a live-cell comparative analysis
Cross et al. Studies on influenza haemagglutinin fusion peptide mutants generated by reverse genetics
Beatch et al. Rubella virus capsid associates with host cell protein p32 and localizes to mitochondria
AU688887B2 (en) Novel mutated viruses, anti-viral compounds and novel methods of making vaccines
González et al. The human immunodeficiency virus type 1 Vpu protein enhances membrane permeability
JP2001514879A5 (https=)
JP2679973B2 (ja) 免疫学的に反応性のウイルス蛋白質の発現
Philipson et al. Structure and Function of Virion Proteins of Adenoviruses¹
Sechoy et al. F protein-F protein interaction within the Sendai virus identified by native bonding or chemical cross-linking.
Teltow et al. Inhibition of herpes simplex virus DNA synthesis by pokeweed antiviral protein
JP2002513813A5 (https=)
Pettersson et al. Molecular and Antigenic Characteristics and Synthesis of Rubella Virus Structural. Proteins
EP0970115A1 (en) Viral peptides with structural homology to protein g of respiratory syncytial virus
Desai et al. Residues of VP26 of herpes simplex virus type 1 that are required for its interaction with capsids
US20050085411A1 (en) Compositions and methods for treating papillomavirus-infected cells
Selvakumar et al. Tumor regression is associated with a specific immune response to the E2 protein of cottontail rabbit papillomavirus
Eron et al. In vitro synthesis of adenovirus core proteins
Stewart et al. In vivo function of a gammaherpesvirus virion glycoprotein: influence on B-cell infection and mononucleosis
Bowen et al. Structure of Sendai viral proteins in plasma membranes of virus-infected cells
WO2000009158A1 (en) Assay for assembly of herpes simplex virus capsid
Soloski et al. DNA-binding proteins in the cytoplasm of vaccinia virus-infected mouse L-cells
Kramer et al. The head structure of a higher plant V-type H+− ATPase is not always a hexamer but also a pentamer
Bagai et al. A glycine to alanine substitution in the paramyxovirus SV5 fusion peptide increases the initial rate of fusion